Are Meta Tags a Regulatory Time Bomb?

This entry was posted in FDA Guidance, Marketing, SEO, Thoughts. Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback: Trackback URL.

Andy Bond, Sudler’s head of Digital Strategy, examines the current state of regulations and recommendations around how pharma brand sites should approach their meta tags in his post on Dose of Digital.

Leave a Reply

Share |